SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J908. A total of 4 filers reported holding SAGE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,452,948 | -58.4% | 70,600 | -5.0% | 0.00% | -100.0% |
| Q2 2023 | $3,493,586 | +14.2% | 74,300 | +1.9% | 0.00% | 0.0% |
| Q1 2023 | $3,058,884 | -20.1% | 72,900 | -27.4% | 0.00% | -50.0% |
| Q4 2022 | $3,829,256 | -14.5% | 100,400 | -12.2% | 0.00% | 0.0% |
| Q3 2022 | $4,480,000 | +276.8% | 114,400 | +210.9% | 0.00% | +100.0% |
| Q2 2022 | $1,189,000 | – | 36,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 72,900 | $11,595,000 | 0.13% |
| SIMPLEX TRADING, LLC | 266 | $4,230,000 | 0.01% |
| JPMORGAN CHASE & CO | 335,000 | $53,282,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |